Pongkiat Kankirawatana
Neurology with Special Qualifications in Child Neurology · Birmingham, ALNPI 1164539995
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,361 of the $1,919 with a category attached, or 70.9%. 10 manufacturers reported payments, led by UCB GmbH at 29.1% of the total. Reporting peaked in 2019 at $874 and has fallen 63.0% since, to $323 in 2025. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in AL, where the typical reported total is $4,193.
Across 20 payments — averaging $95.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB GmbH$557
- Greenwich Biosciences, Inc.$417
- UCB, Inc.$270
- Jazz Pharmaceuticals Inc.$243
- Livanova USA, Inc.$131
- SK Life Science, Inc.$106
- plus $194 from 4 others
Across 27 payments — averaging $24,933 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$473K
- UCB Biosciences Inc.$197K
- Janssen Research & Development, LLC$3K
What the payments were for
- Travel & lodging$55729%
- Food & beverage$1,36171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB GmbH | 1 | $557 |
| Greenwich Biosciences, Inc. | 5 | $417 |
| UCB, Inc. | 3 | $270 |
| Jazz Pharmaceuticals Inc. | 2 | $243 |
| Livanova USA, Inc. | 2 | $131 |
| SK Life Science, Inc. | 1 | $106 |
| Neurelis, Inc. | 1 | $101 |
| Sunovion Pharmaceuticals Inc. | 3 | $48 |
| Natus Medical Incorporated | 1 | $28 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,919 in reported general payments places this provider in the 35th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.
See all neurology with special qualifications in child neurology providers in Alabama →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 14 | $6,300 |
| Levetiracetam | 15 | $448 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Birmingham
- Alyssa ReddyBirmingham$68K
- Alan PercyBirmingham$51K
- Michael LopezBirmingham$22K
- Elizabeth BebinBirmingham$15K
- Amitha AnanthBirmingham$10K
- Jan MathisenBirmingham$8K
- Monisha GoyalBirmingham$8K
- Kathryn LalorBirmingham$3K
- Emily GantzBirmingham$1K
- Katherine ThaggardBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.